Advance in treatment of hyperuricemia by Chinese medicine based on uric acid transporterome.
- Author:
Qi ZHOU
;
Shu-min LIU
- Publication Type:Journal Article
- MeSH:
Animals;
Biological Transport;
Carrier Proteins;
antagonists & inhibitors;
genetics;
metabolism;
Drugs, Chinese Herbal;
therapeutic use;
Humans;
Hyperuricemia;
drug therapy;
metabolism;
Uric Acid;
metabolism
- From:
China Journal of Chinese Materia Medica
2015;40(22):4346-4350
- CountryChina
- Language:Chinese
-
Abstract:
With the development of the quality of life, the morbidity of hyperuricemia is increasing year by year. At the same time, it appears that this disease attacks the young people currently. As the study of pathogenesis of hyperuricemia advanced, a series of uric acid transporters were found during this process. Meanwhile, the definition of transporterome was proposed. They were divided into three groups according to the functions: reabsorption proteins, excretion proteins and skeleton proteins. At moment, the drugs for hyperuricmia mainly include uric acid composition inhibitors and uric acid excretion promoters. Since the excretion of uric acid plays a leading role during the process of attack of hyperurecimia, it makes sense to explore Chinese medicines with clear mechanism targeting the transporterome. Therefore, this paper would focus on transporterome and summarize the mechanisms of Chinese medicines in treating hyperuricemia.
